HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
The peptide-based vaccine induces a t cell-dependent response
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Both companies have been selected for stand-by production by German government
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Subscribe To Our Newsletter & Stay Updated